NCLEX Questions With Rationales / Pharmacology / Drug Classes & Mechanisms
NCLEX Questions With Rationales

Calcium Channel Blockers NCLEX Questions With Rationales

Pharmacology · Drug Classes & Mechanisms·Updated 2026-11-20

What it is

Calcium channel blockers (CCBs) are medications that inhibit calcium entry into cardiac and vascular smooth muscle cells, causing vasodilation and, with certain agents, reduced cardiac conduction and contractility. They are used to manage hypertension, angina, and selected cardiac dysrhythmias, including atrial fibrillation.

CCBs are divided into dihydropyridines and nondihydropyridines. Dihydropyridines include amlodipine and nifedipine, which primarily relax arterial smooth muscle. Nondihydropyridines include verapamil and diltiazem, which also slow heart rate and atrioventricular (AV) node conduction.

What the NCLEX focuses on

  • Amlodipine and nifedipine primarily produce arterial vasodilation, reducing systemic vascular resistance and blood pressure.
  • Verapamil and diltiazem slow SA and AV node activity, making them useful for controlling ventricular rate in selected clients with atrial fibrillation.
  • Common adverse effects include hypotension, dizziness, headache, flushing, and peripheral edema.
  • Verapamil commonly causes constipation because of its effects on gastrointestinal smooth muscle.
  • Verapamil and diltiazem can cause bradycardia, prolonged AV conduction, and heart block.
  • Combining nondihydropyridine CCBs with beta blockers can increase the risk of bradycardia, AV block, and impaired cardiac contractility.
  • Verapamil and diltiazem have negative inotropic effects and require caution in clients with heart failure with reduced ejection fraction.
  • Extended-release formulations must be administered according to their specific product instructions and should not be crushed or chewed when the formulation prohibits it.
  • Grapefruit juice can increase blood concentrations of certain CCBs, particularly verapamil, through inhibition of drug metabolism.

Priority nursing actions

  • Assess blood pressure and apical pulse before administering the medication. Review prescribed hold parameters and withhold the dose when indicated by the order or clinical condition.
  • Assess for symptomatic hypotension, dizziness, syncope, peripheral edema, and changes in cardiac rhythm.
  • Monitor heart rate and ECG findings in clients receiving verapamil or diltiazem, particularly when other medications that slow cardiac conduction are prescribed.
  • Assess clients with heart failure for worsening dyspnea, peripheral edema, pulmonary congestion, and other signs of fluid overload.
  • Administer the prescribed formulation correctly. Do not crush or chew extended-release tablets or capsules unless the specific product instructions permit an alternative method.

Common exam traps

  • Choosing amlodipine for ventricular rate control: wrong because dihydropyridines primarily produce vascular relaxation rather than significant AV node suppression.
  • Choosing verapamil for a client with significant systolic heart failure: wrong because its negative inotropic effect can worsen cardiac function.
  • Choosing continued administration with symptomatic bradycardia: wrong because nondihydropyridines can further slow cardiac conduction.
  • Choosing crushing an extended-release tablet: wrong because crushing can alter the medication's intended release characteristics.
  • Choosing increased dietary fiber as the treatment for peripheral edema: wrong because peripheral edema is a vascular adverse effect, not constipation.

What to teach

  • Teach clients to check blood pressure and pulse as instructed and follow the provider's individualized medication hold parameters.
  • Advise clients to rise slowly from sitting or lying positions to reduce dizziness and fall risk.
  • Teach clients to avoid grapefruit and grapefruit juice unless the prescriber or pharmacist confirms that consumption is appropriate for their specific medication.
  • Encourage adequate dietary fiber and fluid intake, when appropriate, to help manage constipation associated with verapamil.
  • Teach clients to report fainting, severe dizziness, unusually slow heart rate, worsening swelling, or difficulty breathing promptly.
  • Reinforce adherence to the prescribed dosing schedule and explain that extended-release products must be taken according to their individual administration instructions.

2 NCLEX questions with rationales on this topic

From the NCLEXPace question bank. Choose your answer first, then open the correct answer and the full rationale under each question.

Question 1

A client with atrial fibrillation is receiving prescribed diltiazem for ventricular rate control. Before administering the next dose, the nurse assesses an apical pulse of 48 beats/min and reports of dizziness. Which action should the nurse take?

  1. A. Administer the medication and reassess the pulse afterward.
  2. B. Withhold the dose and notify the prescribing provider.
  3. C. Administer the medication with food to reduce dizziness.
  4. D. Give half the dose and recheck the pulse in 1 hour.
Show the correct answer and rationale

Correct answer:

  • Withhold the dose and notify the prescribing provider.

Rationale

Overview

  • Definition: Diltiazem is a nondihydropyridine calcium channel blocker that reduces cardiac conduction and slows AV node activity.
  • Indication: Diltiazem is used for ventricular rate control in selected clients with atrial fibrillation.
  • Adverse effects: Diltiazem can cause bradycardia, hypotension, and AV block.
  • Monitoring: Heart rate, blood pressure, and cardiac conduction require assessment during therapy.

Nursing key points

  • Assess the apical pulse before administering diltiazem.
  • Assess blood pressure and symptoms of hypotension.
  • Recognize dizziness as a possible manifestation of reduced blood pressure or heart rate.
  • Withhold medication when clinical findings meet prescribed hold parameters.
  • Notify the provider about symptomatic bradycardia.

Answer analysis

Nursing actionRationale
Withhold the dose and notify the prescribing provider.Correct. Symptomatic bradycardia requires withholding the medication and notifying the provider for further evaluation.
Administer the medication and reassess the pulse afterward.Not correct. Diltiazem can further reduce heart rate and worsen symptomatic bradycardia.
Administer the medication with food to reduce dizziness.Not correct. Food does not correct the medication-related slowing of cardiac conduction or symptomatic bradycardia.
Give half the dose and recheck the pulse in 1 hour.Not correct. The nurse does not change a prescribed dose; symptomatic bradycardia calls for holding the dose and notifying the provider.
Question 2

A client with hypertension is prescribed extended-release nifedipine. During discharge teaching, the client asks how to take the medication and manage possible adverse effects. Which instructions should the nurse include? Select all that apply.

  1. A. Rise slowly when moving from lying to standing.
  2. B. Crush the extended-release tablet if swallowing becomes difficult.
  3. C. Monitor blood pressure as instructed by the healthcare provider.
  4. D. Report persistent or worsening swelling of the lower extremities.
  5. E. Use grapefruit juice regularly to improve medication absorption.
  6. F. Follow the prescribed instructions for administering the extended-release formulation.
Show the correct answer and rationale

Correct answers:

  • Rise slowly when moving from lying to standing.
  • Monitor blood pressure as instructed by the healthcare provider.
  • Report persistent or worsening swelling of the lower extremities.
  • Follow the prescribed instructions for administering the extended-release formulation.

Rationale

Overview

  • Definition: Nifedipine is a dihydropyridine calcium channel blocker that primarily relaxes arterial smooth muscle.
  • Indication: Nifedipine is used to treat hypertension by reducing vascular resistance and blood pressure.
  • Adverse effects: Common adverse effects include dizziness, headache, flushing, hypotension, and peripheral edema.
  • Administration: Extended-release nifedipine formulations must be administered according to their specific product instructions.

Nursing key points

  • Monitor blood pressure during antihypertensive therapy.
  • Teach clients to change positions slowly to reduce orthostatic symptoms.
  • Recognize peripheral edema as a potential adverse effect.
  • Teach clients to report persistent or worsening lower extremity swelling.
  • Do not crush or chew extended-release formulations when prohibited by product instructions.

Answer analysis

Teaching instructionRationale
Rise slowly when moving from lying to standing.Correct. Changing positions gradually reduces dizziness and the risk of falls associated with hypotension.
Crush the extended-release tablet if swallowing becomes difficult.Not correct. Crushing an extended-release formulation can alter its intended drug release and absorption.
Monitor blood pressure as instructed by the healthcare provider.Correct. Blood pressure monitoring helps evaluate therapeutic response and identify excessive blood pressure reduction.
Report persistent or worsening swelling of the lower extremities.Correct. Peripheral edema is a recognized adverse effect of dihydropyridine calcium channel blockers and should be reported when persistent or worsening.
Use grapefruit juice regularly to improve medication absorption.Not correct. Grapefruit juice can alter the metabolism and blood concentrations of certain calcium channel blockers and is not recommended as a method of improving absorption.
Follow the prescribed instructions for administering the extended-release formulation.Correct. Extended-release products have formulation-specific administration requirements that preserve their intended drug release.
Want more questions on this topic?

The NCLEXPace bank has 3,200+ NCLEX questions with full rationales, sorted by topic, with your progress tracked as you practice. Create your account to start.

Create Account →

More topics in Pharmacology

Proton Pump Inhibitors and Antacids NCLEX Questions With RationalesReviews acid-suppressing medications, administration, adverse effects, drug interactions, and nursing priorities for gastrointestinal bleeding.Statins NCLEX Questions With RationalesReviews statin medications, LDL reduction, adverse effects, drug interactions, laboratory monitoring, and client education.Acetaminophen Overdose NCLEX Questions With RationalesReviews acetaminophen toxicity, overdose stages, diagnostic testing, antidote administration, liver monitoring, and suicide prevention.

Sources

  • National Library of Medicine, MedlinePlus. Verapamil. 2025.
  • National Library of Medicine, MedlinePlus. Diltiazem. 2025.
  • National Library of Medicine, MedlinePlus. Nifedipine. 2025.
Practice the NCLEX questions on this topic

3,200+ NCLEX questions with think-like-a-nurse rationales, unfolding case studies and adaptive readiness exams. Start with free practice questions, then choose a plan when you are ready.

Create Account →